View Rule
View EO 12866 Meetings | Printer-Friendly Version Download RIN Data in XML |
DOL/EBSA | RIN: 1210-AC07 | Publication ID: Spring 2022 |
Title: Prescription Drug and Health Care Spending | |
Abstract:
This interim final rule implements the prescription drug reporting requirements that apply to group health plans and health insurance issuers offering coverage in the group and individual markets under section 204 of title II of Division BB of the Consolidated Appropriations Act, 2021. |
|
Agency: Department of Labor(DOL) | Priority: Economically Significant |
RIN Status: Previously published in the Unified Agenda | Agenda Stage of Rulemaking: Completed Actions |
Major: Yes | Unfunded Mandates: No |
CFR Citation: 29 CFR 2590.716-1 29 CFR 2590.716-2 29 CFR 2590.725-1 to 2590.725-4 | |
Legal Authority: Pub. L. 116-260, Div. BB, Title I and Title II |
Legal Deadline:
None |
|||||||||||||||||||||
Timetable:
|
Regulatory Flexibility Analysis Required: No | Government Levels Affected: Local, State |
Federalism: Yes | |
Included in the Regulatory Plan: No | |
RIN Data Printed in the FR: No | |
Related Agencies: Joint: TREAS/IRS, HHS/CMS; | |
Agency Contact: Amber Rivers Director, Office of Health Plan Standards and Compliance Assistance Department of Labor Employee Benefits Security Administration 200 Constitution Avenue NW, Washington, DC 20210 Phone:202 693-8335 Email: rivers.amber@dol.gov |